SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-19-001280
Filing Date
2019-01-10
Accepted
2019-01-10 08:30:24
Documents
5
Period of Report
2019-01-07
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tv510807_8k.htm 8-K 21897
2 EXHIBIT 10.1 tv510807_ex10-1.htm EX-10.1 67953
3 EXHIBIT 99.1 tv510807_ex99-1.htm EX-99.1 10477
4 GRAPHIC image_001.jpg GRAPHIC 4174
5 GRAPHIC image_002.jpg GRAPHIC 2145
  Complete submission text file 0001144204-19-001280.txt   110891
Mailing Address 3333 LEE PARKWAY SUITE 600 DALLAS TX 75219
Business Address 3333 LEE PARKWAY SUITE 600 DALLAS TX 75219 2149055100
ABEONA THERAPEUTICS INC. (Filer) CIK: 0000318306 (see all company filings)

IRS No.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-15771 | Film No.: 19519297
SIC: 2834 Pharmaceutical Preparations